57 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel … in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person;
are not liable
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
a lawsuit and motion to approve the lawsuit as a class action lawsuit pursuant to the Class Action Lawsuits Law 5766-2006 which was filed against us … and the class period relates to the company's statements between February 23, 2021, and September 19, 2022. The total amount claimed, if the lawsuit
F-3
BLRX
Bioline Rx Ltd
29 Dec 23
Shelf registration (foreign)
4:15pm
breach of the terms of the deposit agreement;
have no obligation to become involved in a lawsuit or other proceeding related to the ADSs … debt securities of the relevant series may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy
6-K
EX-10.1
qt7w zql5
21 Sep 22
Current report (foreign)
8:00am
424B5
9yo1b575vntp elw9y
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-10.1
n40kue6
3 Sep 21
Current report (foreign)
4:30pm
424B5
vqaj5yq
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
fdivowlsc4ro67
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
7y10oyjvgfjr8pqj
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
ponnposck9
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
34odo55sw796pt8h5pxu
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
yo02j0q
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-10.1
hlpobb39cr7dl
25 Sep 20
Current report (foreign)
4:33pm
424B5
lu985o8s2
25 Sep 20
Prospectus supplement for primary offering
4:30pm
POS AM
l8ad awq757dyc
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
424B3
qrwaqxlld97a0063u
2 Jul 20
Prospectus supplement
4:28pm
F-1
pf453av48 st12hpp
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
aolh8vl clsb3mml9
3 Jun 20
Prospectus supplement for primary offering
8:33am